Učitavanje...
Altered pathways and colorectal cancer prognosis
The identification of molecular markers with prognostic value in colorectal cancer is a challenging task that is needed to define therapeutic guidelines. Clinical factors are insufficient to identify those patients with stage II at risk of relapse or those patients with stage III at low risk. There...
Spremljeno u:
Izdano u: | BMC Med |
---|---|
Glavni autori: | , |
Format: | Artigo |
Jezik: | Inglês |
Izdano: |
BioMed Central
2015
|
Teme: | |
Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4389340/ https://ncbi.nlm.nih.gov/pubmed/25885526 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-015-0307-6 |
Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|